Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-09-04

Clinical Trial Update: Colchicine Use in Intracranial Atherosclerotic Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing the use of colchicine for intracranial atherosclerotic disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • COLCHICINE (Colchicine)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: ICAD - Intracranial Atherosclerotic Disease | Phase 2 | Status: RECRUITING